Shukra Pharmaceuticals dividend 2025

SHUKRAPHAR

56.39

2.68 (4.99%)
Last updated on 16 Dec, 2025 | 15:24 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Shukra Pharmaceuticals Dividend Details

Record Date

18-Sep-2025

Dividends Date

18-Sep-2025

Ex Date

18-Sep-2025

Dividend Type

Equity Share

Dividend Per Share

1.00

The Shukra Pharmaceuticals has declared a Equity Share dividend of 1 per share. Investors should note the record date of 18-Sep-2025, and the ex-dividend date 18-Sep-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.

Shukra Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
18-Sep-20250.01Equity Share18-Sep-2025
01-Jan-00010.10Equity Share23-Sep-2024

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
Can Fin Homes Ltd.008-Dec-202519-Dec-202519-Dec-2025

Shukra Pharmaceuticals Dividend FAQs

The latest dividend declared by Shukra Pharmaceuticals is of 0.01 per share for the financial year as announced on 18-Sep-2025.

Registered shareholders who own Shukra Pharmaceuticals’s shares on or before the record date of 18-Sep-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Sep-2025.

You can expect to receive Shukra Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Sep-2025. The record date is when Shukra Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by Shukra Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Shukra Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.